Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Growing Lab Models of Endometrial Cancer From Surgical Tumor Samples

Tests whether tumor tissue from endometrial cancer surgery can be grown into lab models.

Plain-language title generated from the registry record
Registry title: Generation of Endometrial Carcinoma Organoids

Key facts

Where
Roma, ItalySee the site

Where in Italy

  • IRCCS National Cancer Institute "Regina Elena"Roma, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Regina Elena Cancer Institute
Trial code
NCT07258186
Record updated
2 December 2025
Original description
A prospective pilot genetic study to evaluate the feasibility of generating organoids from endometrial tumor tissue collected during surgery, performed according to standard clinical practice. Samples will be collected from collaborating extramural facilities, with the aim of analyzing the impact of transport on tissue viability and the success of organoid culture. This study is for exploratory purposes only, without altering the diagnostic and therapeutic pathways of the participants.Read full original descriptionShow less

Feasibility Study of the Generation of Endometrial Carcinoma Organoids From Tumor Samples Transferred From Extramural Facilities

A prospective pilot genetic study to evaluate the feasibility of generating organoids from endometrial tumor tissue collected during surgery, performed according to standard clinical practice. Samples will be collected from collaborating extramural facilities, with the aim of analyzing the impact of transport on tissue viability and the success of organoid culture. This study is for exploratory purposes only, without altering the diagnostic and therapeutic pathways of the participants.

Inclusion: Age >18 years; Patients with a histological diagnosis of: endometrial cancer, endometrioid histology, any stage of disease (FIGO I-IV), recurrence/metastasis from endometrial endometrioid cancer, and candidates for surgery and/or hysterectomy; Written informed consent (study participation and data processing) must be obtained in person and/or through a legal representative/guardian/support administrator/witness, before any study-specific procedure is performed.

Exclusion: Comorbidities not controlled with adequate medical therapy; Previous radiation treatments to the pelvic region; Endometrial cavity infections (pyometra); Synchronous tumors; Neoadjuvant treatments.

ClinicalTrials.gov NCT07258186